(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Clinical trial NCT05907954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05907954
- Sponsor
- IDEAYA Biosciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2027-04-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.